University of Connecticut

Astellas Pharma Inc. continues to build up a regenerative medicine portfolio, most recently paying $80m up front to develop and commercialize Frequency Therapeutics Inc. 's one-and-only clinical dru

Below is Scrip’s monthly roundup, including information from Strategic Transactions , of recent technology transfer agreements between companies and academic or other research institutions. Amicus,

Below is Scrip’s monthly roundup, including information from Strategic Transactions , of recent technology transfer agreements between companies and academic or other research institutions. Mustang

Start-up RallyBio Inc. , which launched on April 25 with $37m in Series A venture capital, is starting out with a dream team of executives with experience developing, launching and marketing therapie